0240 GMT - Riverstone's 4Q sales volume outlook looks healthy, thanks to increased U.S. demand and a recovery in the electronics sector, UOB Kay Hian analysts write in a report. The Singapore-listed glove maker's 3Q results were in line with expectations, with cleanroom and healthcare gloves recording higher average selling prices and sales volumes, they note. The coming tariffs on China-made gloves could lead to more demand from the U.S., the analysts add. UOB KH maintains the stock's buy rating and target price of S$1.16. Shares are flat at S$1.00. (amanda.lee@wsj.com)
(END) Dow Jones Newswires
November 14, 2024 21:40 ET (02:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments